(205 days)
Not Found
No
The device description and performance studies focus solely on the physical and biological properties of a surgical glove, with no mention of AI or ML technologies.
No.
A therapeutic device is one that treats or alleviates a disease or condition. This device is a surgical glove intended to protect a surgical wound from contamination, not to treat a condition.
No
The device description clearly states its purpose as protecting a surgical wound from contamination by being worn by operating room personnel, not for diagnosing a condition or disease.
No
The device description clearly states it is a physical product (surgical gloves made of natural rubber) and the performance studies focus on physical and biological properties, not software functionality.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "be worn by operating room personnel to protect a surgical wound from contamination." This is a physical barrier function, not a diagnostic test performed on a sample taken from the human body.
- Device Description: The description focuses on the physical properties and standards related to surgical gloves (material, sterility, size, standards like ASTM D3577). There is no mention of reagents, assays, or any components used to analyze biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in samples
- Providing information for diagnosis, monitoring, or treatment decisions based on sample analysis.
This device is clearly a medical device intended for physical protection during surgery, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The Sterilized Latex Surgical Glove is a device made of natural rubber intended to be worn by operating room personnel to protect a surgical wound from contamination.
Product codes
KGO
Device Description
The proposed sterilized latex surgical gloves are powder-free, sterile, single use, surgical gloves intended to be worn by operating room personnel to protect a surgical wound from contamination. The gloves are natural color (no colorant added). The gloves are offered in sizes of 6.5, 7, 7.5, 8, 8.5, 9.
The gloves are designed and manufactured in accordance with the ASTM D3577-19 standard.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
operating room personnel
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility Testing:
- Study Type: Biocompatibility Testing according to ISO 10993-1:2018.
- Tests Conducted:
- ISO 10993-05:2009 Biological Evaluation of Medical Devices - Part 5: Tests for In Vitro Cytotoxicity
- ISO 10993-10:2010 Biological Evaluation of Medical Devices - Part 10: Tests for Irritation And Skin Sensitization
- ISO 10993-11:2017 Biological evaluation of medical device – Part 11: Tests for systemic toxicity
- Results:
- Cytotoxicity: Cytotoxic (Pass)
- Irritation: Non-irritant (Pass)
- Sensitization: Non-sensitizing (Pass)
- Systemic Toxicity: No systemic toxicity concern (Pass)
- Pyrogen: Non-pyrogenic (Pass)
Performance Testing:
- Study Type: Physical performance testing and extractable protein testing.
- Standards followed: ASTM D3577-19, ASTM D5151-19, ASTM D6124-06 (Reapproved 2017), ASTM D5712-2015, ASTM F1929-15, ASTM D3078-02 (2013), ASTM F88/F88M-15, ASTM D7160-16.
- Key Results:
- Dimensions (Length, Width, Thickness): Met specified ranges for all sizes.
- Physical Properties (Tensile Strength, Ultimate Elongation, Stress at 500% elongation): Met requirements both before and after aging.
- Watertight Test: AQL 1.5, passed (No glove appeared leakage for the size of 750 gloves tested).
- Residual Powder: 1.2-1.5mg/glove (Passed requirement of
§ 878.4460 Non-powdered surgeon's glove.
(a)
Identification. A non-powdered surgeon's glove is a device intended to be worn on the hands of operating room personnel to protect a surgical wound from contamination. A non-powdered surgeon's glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" followed by the words "U.S. Food & Drug Administration".
March 23, 2023
Suzhou Colour-way New Material Co., Ltd. % Ivv Wang Technical Manager Shanghai Sungo Management Consulting Company Limited 14 th Floor, 1500# Central Avenue Shanghai, Shanghai 200122 China
Re: K222620
Trade/Device Name: Sterilized Latex Surgical Gloves Regulation Number: 21 CFR 878.4460 Regulation Name: Non-Powdered Surgeon's Glove Regulatory Class: Class I, reserved Product Code: KGO Dated: February 24, 2023 Received: February 24, 2023
Dear Ivy Wang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Bifeng Qian -S
Bifeng Qian, M.D., Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K222620
Device Name Sterilized Latex Surgical Gloves
Indications for Use (Describe)
The Sterilized Latex Surgical Glove is a device made of natural rubber intended to be worn by operating room personnel to protect a surgical wound from contamination.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) Summary
K222620
(As requirement by 21 CFR 807.92)
Date prepared: March 23, 2023
A. Applicant:
Name: Suzhou Colour-way New Material Co., Ltd. Address: No. 20, Anmin Road, Huangdai Town, Xiangcheng District 215152, Suzhou City,Jiangsu province, PEOPLE'S REPUBLIC OF CHINA Contact: XU Yongping Title: General Manager Tel: +86- 13862093201/+86-0512-65371017 Email: qa(a)colourway.com
Submission Correspondent: Primary contact: Ms. Ivy Wang Shanghai SUNGO Management Consulting Co., Ltd. Room 1401, Dongfang Building, 1500# Century Ave., Shanghai 200122, China Tel: +86-21-58817802 Email: haiyu.wang@sungoglobal.com Secondary contact: Mr. Raymond Luo Room 1401, Dongfang Building, 1500# Century Ave., Shanghai 200122, China Tel: +86-21-68828050 Email: fda.sungo@@gmail.com
B. Device:
Trade Name: Sterilized Latex Surgical Gloves Model: 6.5.7.7.5.8.8.5.9
Regulatory Information Classification Name: Surgeon's Gloves Classification: Class I Product code: KGO Regulation Number: 21 CFR 878.4460 Review Panel: General Hospital
C. Predicate device:
K212596 Applicant: Amazing Rubber Products Pvt. Ltd. Device Name: Sterile Latex Surgical Gloves Power Free
4
Regulatory Information Classification Name: Surgeon's Gloves Classification: Class I Product code: KGO Regulation Number: 21 CFR 878.4460 Review Panel: General Hospital
D. Indications for use of the device:
The Sterilized Latex Surgical Glove is a device made of natural rubber intended to be worn by operating room personnel to protect a surgical wound from contamination.
E. Device Description
The proposed sterilized latex surgical gloves are powder-free, sterile, single use, surgical gloves intended to be worn by operating room personnel to protect a surgical wound from contamination. The gloves are natural color (no colorant added). The gloves are offered in sizes of 6.5, 7, 7.5, 8, 8.5, 9.
The gloves are designed and manufactured in accordance with the ASTM D3577-19 standard.
| Device | Proposed Device | Predicate Device | Result |
|---|---|---|---|
| 510K # | K222620 | K212596 | - |
| Manufacturer | Suzhou Colour-way New Material | ||
| Co., Ltd. | Amazing Rubber Products Pvt. Ltd. | - | |
| Product Name | Sterilized Latex Surgical Gloves | Sterile Latex Surgical Gloves Power | |
| Free | Similar | ||
| Product Code | KGO | KGO | Same |
| Regulation Number | 21 CFR 878.4460 | 21 CFR 878.4460 | Same |
| Indications for use | The Sterilized Latex Surgical Glove | ||
| is a device made of natural rubber | |||
| intended to be worn by operating | |||
| room personnel to protect a surgical | |||
| wound from contamination. | A Sterile Latex Surgical Gloves | ||
| Powder Free is a device made of | |||
| natural rubber intended to be worn | |||
| by operating room personnel to | |||
| protect a surgical wound from | |||
| contamination. | Same | ||
| Powder/Powder free | Powder free | Powder free | Same |
| Material | Natural rubber | Natural rubber | Same |
| Classification as per | |||
| ASTM D3577-09, | |||
| Standard Specification for | |||
| Rubber Surgical Gloves | Type I-gloves coumpounded primary | ||
| from natural rubber latex | Type I-gloves coumpounded primary | ||
| from natural rubber latex | |||
| Size | 6.5 | ||
| 7.0 | |||
| 7.5 | 6.0 | ||
| 6.5 | |||
| 7.0 | Similar |
F. Summary of Technological Characteristics
Table 1 General Comparison of Proposed and Predicate Devices
5
| 8.0 | 7.5 | ||
|---|---|---|---|
| 8.5 | 8.0 | ||
| 9.0 | 8.5 | ||
| 9.0 | |||
| Sterilization | Radiation | ||
| SAL-10-6 | ETO/as well as Radiation, | ||
| SAL-10-6 | Similar | ||
| Use | Single use | Single use | Same |
| Label and Labeling | Meet FDA's label requirements | Meet FDA's label requirements | Same |
| Type of use | OTC | OTC | Same |
| Shelf-life | Three years | Three years | Same |
Table 2 Technical Comparison of Proposed and Predicate Devices
| Characteristic | Subject device | Predicate device
K212596 | Comparison |
|-------------------------------------------------------|----------------------------------------------------------------------------------------------------------|---------------------------------------------------|------------|
| Dimensions
Length: Min 265mm | 6.5: 272-278mm
7.0: 274-279mm
7.5: 276-283mm
8.0: 278-284mm
8.5: 279-287mm
9.0: 282-288mm | 486mm | Different |
| Width | | | Similar |
| 6.5 (83±6mm) | 6.5: 84-85mm | 6.5 (87mm) | |
| 7.0 (89±6mm) | 7.0: 90-92mm | 7.0 (91mm) | |
| 7.5 (95±6mm) | 7.5: 95-97mm | 7.5 (97mm) | |
| 8.0 (102±6mm) | 8.0: 103-105mm | 8.0 (103mm) | |
| 8.5 (108±6mm) | 8.5: 108-110mm | 8.5 (110mm) | |
| 9.0 (114±6mm) | 9.0: 114-116mm | 9.0 (116mm) | |
| Cuff, Palm, Finger Tip
Min 0.10mm | Cuff: 0.14-0.16mm
Palm:0.18-0.21mm
Finger: 0.22-0.25mm | Cuff: 0.16mm
Palm:0.21mm
Finger Tip: 0.33mm | Similar |
| Tensile Strength
24Mpa minimum
(Before aging) | 26.9-29.3MPa | 28.61Mpa | Similar |
| Ultimate Elongation
750% minimum
(Before aging) | 800-950% | 871% | Similar |
| Stress at 500%
5.5 Mpa Max
(Before aging) | 3.3-4.9MPa | 5.1Mpa | Similar |
| Tensile Strength
18Mpa minimum
(after aging) | 21-26.3MPa | 24.12Mpa | Similar |
6
| Ultimate Elongation
560% minimum
| (after aging) | 650-790% | 732% | Similar |
|---|---|---|---|
| Freedom from holes | |||
| AQL 1.5 | AQL 1.5 | AQL 1.0 | Different |
| Powder residue for powder | |||
| free glove powder content | |||
| Performance Testing |
Physical performance testing of the proposed device were conducted as per ASTM D3577-19 Standard Specification for Rubber Surgical Gloves. Extractable Protein Test was conducted to for the determination of protein levels in the gloves according to ASTM D5712-2015 Standard Test Method for Analysis of Aqueous Extractable Protein in Latex, Natural Rubber, and Elastomeric Products Using the Modified Lowry Method.
To summarize, the performance testing of the subject device were conducted to adequately demonstrate the effectiveness of the device in accordance with the relevant test methods cited below:
· ASTM D3577-19 Standard Specification for Rubber Surgical Gloves.
· ASTM D5151-19 Standard Test Method for Detection of Holes in Medical Gloves
· ASTM D6124-06 (Reapproved 2017) Standard Test Method for Residual Powder on Medical Gloves
· ASTM D5712-2015 Standard Test Method for Analysis of Aqueous Extractable Protein in Latex, Natural Rubber, and Elastomeric Products Using the Modified Lowry Method
· ASTM F1929-15 Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration
· ASTM D3078-02 (2013) Standard Test Method for Determination of Leakage in Flexible Packaging by Bubble Emission Method
• ASTMF88/F88M-15 Standard Test Method for Seal Strength of Flexible Barrier Materials
- · ASTM D7160-16 Determination of Expiration Date for Medical Gloves
Performance testing and biocompatibility testing are summarized in below table 3.
| Test Methodology | Purpose | Acceptance Criteria | Result |
|---|---|---|---|
| Dimension | |||
| ASTM D3577-09 | To determine the length | ||
| of the gloves | 265mm, min | Pass | |
| 6.5: 272-278mm | |||
| 7.0: 274-279mm | |||
| 7.5: 276-283mm | |||
| 8.0: 278-284mm | |||
| 8.5: 279-287mm | |||
| 9.0: 282-288mm | |||
| To determine the width | |||
| of the gloves | Size 6.5: 83 ± 6 mm | ||
| Size 7: 89 ± 6 mm | |||
| Size 7.5: 95 ± 6 mm | Pass | ||
| 6.5: 84-85mm | |||
| 7.0: 90-92mm | |||
| 7.5: 95-97mm | |||
| Size 8: 102 ± 6 mm | 8.0: 103-105mm | ||
| Size 8.5: 108 ± 6 mm | 8.5: 108-110mm | ||
| Size 9: 114 ± 6 mm | 9.0: 114-116mm | ||
| To determine the | |||
| thickness of the gloves | Pass | ||
| Palm:0.10, min | Cuff: 0.14-0.16mm | ||
| Finger: 0.10 min | Palm:0.18-0.21mm | ||
| Cuff: 0.10 min | Finger: 0.22-0.25mm | ||
| To determine the | |||
| physical property of | |||
| tensile strength of the | |||
| gloves | Before Aging | Pass | |
| Tensile strength 24Mpa | |||
| min for all sizes | Before Aging | ||
| 26.9-29.3MPa or all sizes | |||
| After Aging | After Aging | ||
| Tensile strength 18Mpa | |||
| min for all sizes | 21-26.3MPa for all sizes | ||
| Physical Properties | |||
| ASTM D3577-09 | To determine the | ||
| physical property of | |||
| ultimate elongation of the | |||
| gloves | Before Aging | ||
| 750% min for all sizes | Before Aging | ||
| 800%-950% for all sizes | |||
| After Aging | |||
| 560% min for all sizes | After Aging | ||
| 650%-790%for all sizes | |||
| To determine the | |||
| physical properties of | |||
| stress at 500% elongation | |||
| of the gloves | Before Aging | ||
| 5.5Mpa, max for all sizes | Before Aging | ||
| 3.3-4.9MPa | |||
| Watertight Test | |||
| ASTM D5151-19 | To determine the | ||
| watertightness of the | |||
| gloves | AQL 1.5 | Pass | |
| No glove appears leakage for | |||
| the size of 750 gloves have | |||
| been tested. | |||
| Residual power | |||
| ASTM D6124-06 | |||
| (17) | To determine the residual | ||
| power in the gloves. | 2mg per glove or less | Pass | |
| 1.2-1.5mg/glove for all tested | |||
| gloves | |||
| Aqueous soluble | |||
| protein content | |||
| ASTM D5712-15 | To determine the | ||
| aqueous soluble protein | |||
| content in the gloves | 200 $µ$ g/dm² max for all | ||
| sizes. | Pass | ||
| 93.6-125.1 ug/dm² for all tested | |||
| gloves. | |||
| Irritation | |||
| ISO 10993-10 | To evaluate the potential | ||
| skin irritation caused by | |||
| test article contact with | |||
| the skin surface of | |||
| rabbits. | Negligibly irritating | Pass | |
| Under the condition of this | |||
| study, the device is negligibly | |||
| irritating. | |||
| Sensitization | |||
| ISO 10993-10 | The test was designed to | ||
| evaluate the potential of a | |||
| test article to cause skin | |||
| sensitization. | Non-sensitizing | Pass | |
| Under the conditions of the | |||
| study, the device is | |||
| non-sensitizing | |||
| Systemic toxicity | |||
| ISO 10993-11 | The test article was | ||
| evaluated to determine | |||
| whether leachables | Non-systemic toxicity | Pass | |
| Under the conditions of the | |||
| study, there is no mortality or | |||
| extracted from the test | |||
| article would cause acute | |||
| systemic toxicity | |||
| following injection into | |||
| mice. | evidence of systemic toxicity | ||
| from the extracts. | |||
| Pyrogen | |||
| ISO 10993-11 | The test article was | ||
| evaluated for the risks of | |||
| febrile reaction in the | |||
| rabbit to the | |||
| administration by | |||
| injection. | Non-pyrogenic | Pass | |
| Under the conditions of the | |||
| study, the test articles would not | |||
| considered be febrile reaction. | |||
| Bacterial Endotoxin | |||
| USP 43 | To determine the | ||
| bacterial endotoxin of | |||
| each sample meet the | |||
| requirement of endotoxin | |||
| limit. |